Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 9.632
Filtrar
3.
Lima; Perú. Ministerio de Salud; 20200400. 4 p.
Monografía en Español | LILACS, LIPECS | ID: biblio-1095540

RESUMEN

El documento contiene la conformación del Grupo de Trabajo con el objeto de asesorar en materia de innovación de tecnologías sanitarias para la atención y manejo del COVID-19.


Asunto(s)
Coronavirus , Comités Consultivos , Tutoría
6.
Ann Allergy Asthma Immunol ; 124(5): 424-440.e17, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32336463

RESUMEN

Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus. Many new studies have been reported recently that describe EoE management. An expert panel was convened by the American Gastroenterological Association Institute and the Joint Task Force on Allergy-Immunology Practice Parameters to provide a technical review to be used as the basis for an updated clinical guideline. This technical review was developed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. Eighteen focused EoE management questions were considered, with 15 answered using the GRADE framework and 3 with a narrative summary. There is moderate certainty in the evidence that topical glucocorticosteroids effectively reduce esophageal eosinophil counts to <15 per high-power field over a short-term treatment period of 4-12 weeks, but very low certainty about the effects of using topical glucocorticosteroids as maintenance therapy. Multiple dietary strategies may be effective in reducing esophageal eosinophil counts to <15 per high-power field over a short-term treatment period, with moderate certainty for elemental diets, low certainty for empiric 2-, 4-, and 6-food elimination diets, and very low certainty that allergy-based testing dietary eliminations have a higher failure rate compared to empiric diet elimination. There is very low certainty for the effect of proton pump inhibitors in patients with esophageal eosinophilia. Although esophageal dilation appears to be relatively safe, there is no evidence that it reduces esophageal eosinophil counts. There is very low certainty in the effects of multiple other medical treatments for EoE: anti-interleukin-5 therapy, anti-interleukin-13 therapy, anti-IgE therapy, montelukast, cromolyn, and anti-TNF therapy.


Asunto(s)
Dieta , Esofagitis Eosinofílica/terapia , Glucocorticoides/uso terapéutico , Inmunoterapia/métodos , Comités Consultivos , Alérgenos/inmunología , Alergia e Inmunología , Esofagitis Eosinofílica/epidemiología , Testimonio de Experto , Humanos , Comunicación Interdisciplinaria , Guías de Práctica Clínica como Asunto , Inhibidores de la Bomba de Protones/uso terapéutico
8.
Br J Nurs ; 29(8): 484-485, 2020 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-32324454

RESUMEN

Professor Alan Glasper, from the University of Southampton, discusses how the Care Quality Commission and the Nursing and Midwifery Council are working during the COVID-19 pandemic.


Asunto(s)
Comités Consultivos , Infecciones por Coronavirus/epidemiología , Pandemias , Neumonía Viral/epidemiología , Garantía de la Calidad de Atención de Salud/organización & administración , Infecciones por Coronavirus/enfermería , Enfermería de Cuidados Críticos , Humanos , Neumonía Viral/enfermería , Medicina Estatal , Reino Unido/epidemiología
9.
Lima; Perú. Ministerio de Salud; 20200300. 3 p.
Monografía en Español | LILACS, LIPECS | ID: biblio-1087783

RESUMEN

El documento contiene la conformación del Grupo de Trabajo con el objeto de asesoraren los temas y materia de atención y manejo del COVID-19


Asunto(s)
Especialización , Coronavirus , Comités Consultivos
11.
Lancet Haematol ; 7(4): e329-e341, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32220342

RESUMEN

Sickle cell disease is a life-threatening inherited condition designated as a public health priority by WHO. Increased longevity of patients with sickle cell disease in high-income, middle-income, and low-income countries present unprecedented challenges for all settings; however, a globally standardised solution for patient transition from paediatric to adult sickle cell disease health care is unlikely to address the challenges. We established a task force of experts from a multicountry (the USA, Europe, Middle East, and Africa) consortium. We combined themes from the literature with viewpoints from members of the task force and invited experts to provide a global overview of transition care practice, highlighting barriers to effective transition care and provide baseline recommendations that can be adapted to local needs. We highlighted priorities to consider for any young person with sickle cell disease transitioning from paediatric to adult health care: skills transfer, increasing self-efficacy, coordination, knowledge transfer, linking to adult services, and evaluating readiness (the SICKLE recommendations). These recommendations aim to ensure appropriate benchmarking of transition programming, but multisite prospective studies are needed to address this growing public health need.


Asunto(s)
Anemia de Células Falciformes/patología , Comités Consultivos , Niño , Prestación de Atención de Salud , Humanos , Gestión del Conocimiento , Autoeficacia , Transición a la Atención de Adultos
13.
J Frailty Aging ; 9(1): 4-8, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32150207

RESUMEN

Biomarkers of frailty and sarcopenia are essential to advance the understanding of these conditions of aging and develop new diagnostic tools and effective treatments. The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force - a group of academic and industry scientists from around the world -- met in February 2019 to discuss the current state of biomarker development for frailty and sarcopenia. The D3Cr dilution method, which assesses creatinine excretion as a biochemical measure of muscle mass, was suggested as a more accurate measure of functional muscle mass than assessment by dual energy x-ray absorptiometry (DXA). Proposed biomarkers of frailty include markers of inflammation, the hypothalamic-pituitary-adrenal (HPA) axis response to stress, altered glucose insulin dynamics, endocrine dysregulation, aging, and others, acknowledging the complex multisystem etiology that contributes to frailty. Lack of clarity regarding a regulatory pathway for biomarker development has hindered progress; however, there are currently several international efforts to develop such biomarkers as tools to improve the treatment of individuals presenting these conditions.


Asunto(s)
Fragilidad , Sarcopenia , Comités Consultivos , Biomarcadores , Congresos como Asunto , Humanos
14.
J Frailty Aging ; 9(1): 9-13, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32150208

RESUMEN

For clinical studies of sarcopenia and frailty, clinically meaningful outcome measures are needed to monitor disease progression, evaluate efficacy of interventions, and plan clinical trials. Physical performance measures including measures of gait speed and other aspects of mobility and strength have been used in many studies, although a definition of clinically meaningful change in performance has remained unclear. The International Conference on Frailty and Sarcopenia Research Task Force (ICFSR-TF), a group of academic and industry scientists investigating frailty and sarcopenia, met in Miami Beach, Florida, USA in February 2019 to explore approaches for establishing clinical meaningfulness in a manner aligned with regulatory authorities. They concluded that clinical meaningful change is contextually dependent, and that both anchor- based and distribution-based methods of quantifying physical function are informative and should be evaluated relative to patient-reported outcomes. In addition, they identified additional research needed to enable setting criteria for clinical meaningful change in trials.


Asunto(s)
Fragilidad/fisiopatología , Rendimiento Físico Funcional , Sarcopenia/fisiopatología , Comités Consultivos , Congresos como Asunto , Humanos , Evaluación de Resultado en la Atención de Salud
16.
Br J Nurs ; 29(4): 250-251, 2020 Feb 27.
Artículo en Inglés | MEDLINE | ID: mdl-32105535

RESUMEN

John Tingle, Lecturer in Law, Birmingham Law School, University of Birmingham, discusses some recent patient reports and crisis events.


Asunto(s)
Informes Anuales como Asunto , Seguridad del Paciente , Medicina Estatal/legislación & jurisprudencia , Comités Consultivos , Femenino , Humanos , Servicios de Salud Materna/normas , Embarazo , Calidad de la Atención de Salud , Medicina Estatal/normas , Reino Unido
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA